Vialwirebiotech, curated
September 30, 2026, 9:23 PM
September 14, 2026
- 4:41 PM · BioPharma Dive4:41 PMSummit, Akeso look to shed PD-1/VEGF drug doubts with latest study results — BioPharma Dive
- 12:30 PM · BioPharma Dive12:30 PMAstraZeneca’s newly approved pill fails frontline breast cancer study — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMPediatric PRVs reaching record high, as fees drop, price soars — BioWorld
- 11:46 AM · BioPharma Dive11:46 AMCellectis quits CAR-Ts and pivots to ‘in vivo’ gene editing — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMCU Anschutz gains IND clearance for CAR T-cell therapy — BioWorld
- 9:00 AM · BioWorld9:00 AMModalis partners with Exegenesis Bio to advance MDL-201 — BioWorld
- 9:00 AM · BioWorld9:00 AMPrelude’s KAT6A selective degrader gains IND approval — BioWorld
- 9:00 AM · BioWorld9:00 AMTreeline Biosciences divulges new KRAS G12C/G12D inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMBial-Portela & Ca identifies new orexin OX2 receptor agonists — BioWorld
- 9:00 AM · BioWorld9:00 AMNIH grant supports Vincere’s kidney-focused USP30 inhibitor — BioWorld
- 9:00 AM · BioWorld9:00 AMQilu Pharmaceutical synthesizes new PLK4 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMRoche reports new APLNR agonists — BioWorld
- 9:00 AM · BioWorld9:00 AMShanghai De Novo Pharmatech patents new ADCs targeting HER2 or FR-α — BioWorld
- 9:00 AM · BioWorld9:00 AMTRI-611 shows antitumor efficacy in ALK+ NSCLC — BioWorld
- 9:00 AM · BioWorld9:00 AMPreclinical data support DMR-001 in CALR-mutant MPNs — BioWorld
- 9:00 AM · BioWorld9:00 AMAstrazeneca reports discovery of NNMT inhibitor for cardiorenal disease — BioWorld
- 7:00 AM · Drug Discovery World7:00 AMRatio Therapeutics and RayzeBio advance novel radiopharmaceuticals — Drug Discovery World
- 6:00 AM · Drug Discovery World6:00 AM€3.1 million to support Fragile X syndrome programme — Drug Discovery World
- 5:00 AM · Drug Discovery World5:00 AMPhase I trial shows Parkinson’s peptide crosses blood-brain barrier — Drug Discovery World
- 4:41 AM · FT — Pharmaceuticals4:41 AMNovo ditches Nordisk from name as drugmaker attempts revival — FT — Pharmaceuticals
- 12:59 AM · SCMP — Tech12:59 AMData from Greater Bay Area’s 88 million residents to help improve healthcare policy: GSK — SCMP — Tech